EX-2 3 dex2.htm SCHEDULE OF PURCHASERS TO THE SECURITIES PURCHASE AGREEMENT Schedule of Purchasers to the Securities Purchase Agreement

Exhibit 2

Schedule of Purchasers

 

Name and Address

 

Number of
Shares of
Common Stock

 

Number of
Warrants

 

Aggregate
Purchase Price

 


 


 


 


 

MDS Life Sciences Technology Fund II NC Limited Partnership
c/o MDS Capital Corp.
100 International Blvd.
Toronto, Ontario
M9W 6J6
Attention: Christine Veira, Legal Dept.

 

1,041,666

 

364,584

 

$   2,250,000.72

 

 

 

 

 

 

 

 

 

MDS Life Sciences Technology Fund II Quebec Limited Partnership
1550 Metcalfe Street
Suite 602
Montreal, Quebec H3A 1X6

with a copy to:

Legal Department
MDS Capital Corp.
100 International Blvd.
Toronto, Ontario
M9W 6J6
Attention: Christine Veira, Legal Dept.

 

347,222

 

121,528

 

$      749,999.52

 

 

 

 

 

 

 

 

 

MLII Co-Investment Fund NC Limited Partnership
c/o MDS Capital Corp.
100 International Blvd.
Toronto, Ontario
M9W 6J6
Attention: Christine Veira, Legal Dept.

 

462,962

 

162,037

 

$   1,000,000.08

 

 


 


 

Name and Address

 

Number of
Shares of
Common Stock

 

Number of
Warrants

 

Aggregate
Purchase Price

 


 


 


 


 

SC Biotechnology Development Fund LP
One Capital Place
P.O. Box 1787 GT Grand Cayman
Cayman Islands
Attention: Eve Wilson

with a copy to:

Legal Department

MDS Capital Corp.
100 International Blvd.
Toronto, Ontario
M9W 6J6
Attention: Christine Veira, Legal Dept.

 

462,962

 

162,037

 

$   1,000,000.00

 

 

 

 

 

 

 

 

 

HBM BioVentures (Cayman) Ltd.
Unit 10 Eucalyptus Bldg.
Crewe Road
P.O. Box 30852 SMB
Grand Cayman, Cayman Islands
Attention: John Arnold

 

1,852,000

 

648,200

 

$   4,000,320.00

 

 

 

 

 

 

 

 

 

Biovail Laboratories Incorporated
Chelston Park, Building 2, Ground Floor,

Collymore Rock, St. Michael, Barbados, West Indies

 

1,626,154

 

569,154

 

3,512,492.64

 

 

 

 

 

 

 

 

 

Special Situations Private Equity Fund, L.P.
153 East 53rd Street
New York, NY 10022

 

601,851

 

210,648

 

$   1,299,998.16

 

 

 

 

 

 

 

 

 

Special Situations Cayman Fund, L.P.
153 East 53rd Street
New York, NY 10022

 

185,185

 

64,815

 

$      399,999.60

 

 

 

 

 

 

 

 

 

Special Situations Fund III, L.P.
153 East 53rd Street
New York, NY 10022

 

601,851

 

210,648

 

$   1,299,998.16

 

 


2


 

Name and Address

 

Number of
Shares of
Common Stock

 

Number of
Warrants

 

Aggregate
Purchase Price

 


 


 


 


 

H&Q Healthcare Investors
c/o Hambrecht & Quist Capital Management LLC
30 Rowes Wharf, 4th Floor
Boston, MA 02110-3328

 

833,333

 

291,667

 

$   1,799,999.28

 

 

 

 

 

 

 

 

 

H&Q Life Sciences Investors
c/o Hambrecht & Quist Capital Management LLC
30 Rowes Wharf, 4th Floor
Boston, MA 02110-3328

 

555,555

 

194,445

 

$   1,199,998.80

 

 

 

 

 

 

 

 

 

Easton Hunt Capital Partners, L.P.
641 Lexington Avenue, 21st Floor
New York, NY 10022

 

231,481

 

81,019

 

$      499,998.96

 

 

 

 

 

 

 

 

 

Quogue Capital, LLC
1285 Avenue of the Americas
35th Floor
New York, NY 10019

 

295,000

 

103,250

 

$      637,200.00

 

 

 

 

 

 

 

 

 

Donald G. Drapkin
35 East 62nd Street
New York, NY 10021

 

162,037

 

56,713

 

$      350,000.00

 

Total

 

9,259,259

 

3,240,745

 

$ 20,000,005.92

 


3